Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Midgut Neuroendocrine Tumors × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 50 Pancreatic Neoplasms 6 Gastrointestinal Neoplasms 6 Stomach Neoplasms 5 Carcinoma, Hepatocellular 5 Colorectal Neoplasms 4 Rectal Neuroendocrine Tumor 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Thyroid Neoplasms 2 Rectal Neoplasms 2 Neoplasms 2 Gastrointestinal Stromal Tumors 2 Gastro-enteropancreatic neuroendocrine tumor 2 Colonic Neoplasms 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Carcinoid Tumor 2 Biliary Tract Neoplasms 2 Appendiceal Neoplasms 2 Anus Neoplasms 2 Visceral Pain 1 Serotonin Syndrome 1 Recurrence 1 Rectal Neuroendocrine Tumors 1 Pheochromocytoma 1 Patients With Gastroenteropancreatic Neuroendocrine Tumors 1

Interventions

Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡